Lyme Disease Supplements: Herbs, Safety, and the Real Evidence
If you have a tick bite, a spreading rash, or a week of fevers and aching joints, see a clinician today. Not a supplement. Lyme disease is a bacterial infection, and antibiotics are the treatment with the strongest evidence. This guide covers what comes next for natural remedies for Lyme disease: what the herb research shows, what can interact with your medication, and what to skip. A capsule does not replace doxycycline. That does not mean there is nothing you can do.
If you have a tick bite, an expanding rash, fever, chills, headache, or muscle aches, see a clinician for antibiotics now. Do not try herbs first or wait for a test result.
Red flags need urgent care, not a supplement: facial drooping or palsy, severe headache, neck stiffness, heart palpitations, fainting, shortness of breath, chest pain, severe joint swelling, or any new neurologic symptom. These can point to neurologic or cardiac Lyme disease and need prompt medical assessment.
Start Here: Tick Bite, Rash, or Sudden Symptoms
Early Lyme disease often shows up as a red or pink rash that expands over days. It may look like a bullseye, or it may not. Some people never see a tick or a rash.
Common early signs include fever, chills, fatigue, headache, and muscle or joint aches.
The CDC notes that most cases are treated with 10 days to 4 weeks of antibiotics, usually doxycycline, amoxicillin, or cefuroxime axetil. The choice depends on your symptoms, age, allergies, and pregnancy.
With early treatment, most people recover quickly and completely.
Why Antibiotics Come First
The 2020 guideline from the Infectious Diseases Society of America, the American Academy of Neurology, and the American College of Rheumatology is the standard of care. It covers prevention, diagnosis, and treatment across the main clinical forms.
Lyme disease is caused by a bacterium, Borrelia burgdorferi, and antibiotics can clear it in most early cases. No supplement has been shown to do that in a person.
So the rule does not bend: finish the antibiotics your clinician prescribed. Do not skip, delay, shorten, or swap them for a herbal protocol.
Supplements fit alongside treatment and after it, for symptoms that linger. Never instead of it. If a product page tells you otherwise, close the tab.
Post-Treatment Lyme Disease Syndrome, Explained Honestly
Some people finish a full, correct course of antibiotics and still feel unwell. Fatigue, aching muscles, joint pain, and trouble thinking can last for months. This is real, and it is not in your head.
Roughly 10% to 20% of treated patients report symptoms that persist. A 2022 cohort study found that 13.7% of people with prior Lyme disease met criteria for post-treatment Lyme disease, compared with 4.1% of people without prior Lyme. The prior Lyme group was about 5.28 times as likely, with 8 to 15 times the odds of moderate or severe fatigue and muscle pain.
The condition is usually called post-treatment Lyme disease syndrome, or PTLDS. It means fatigue, widespread pain, and cognitive trouble lasting more than six months after documented, adequately treated Lyme disease.
What PTLDS Is Not
PTLDS is not proof that the bacteria are still alive. Brain fog, memory trouble, and word-finding problems are real and common. Our guide to brain and memory support covers the general levers. Thyroid problems, sleep disorders, anemia, and autoimmune disease can look similar, so those are worth ruling out.
If fatigue is your main symptom, our overview of supplements for chronic fatigue covers what has evidence and what does not.
Why Longer Antibiotics Did Not Help
If persistent symptoms came from bacteria hiding in the body, longer antibiotics should help. Three randomized trials tested that idea, and none worked.
- Klempner 2001 (NEJM): two trials gave IV ceftriaxone for 30 days, then oral doxycycline for 60 days, versus placebo. There was no significant difference in symptoms, and the trial stopped early for futility.
- Fallon 2008 (Neurology): 10 weeks of IV ceftriaxone in Lyme encephalopathy produced a moderate cognitive improvement at week 12 that did not hold at week 24. Adverse events occurred in 26.1% of the antibiotic group versus 7.1% of the placebo group.
- Berende 2016 (NEJM): 12 weeks of doxycycline, or clarithromycin plus hydroxychloroquine, versus placebo after a short course of ceftriaxone in patients with persistent symptoms attributed to Lyme disease. There was no significant difference in physical quality of life at week 14.
This matters for chronic Lyme supplements. If months of powerful antibiotics did not resolve the symptoms, a capsule sold on a "kill the persisters" story has an even weaker basis. The logic that sells herbal protocols rests on the same idea.
What the French Guideline Recommends
In 2025, the French national health authority published guidance on PTLDS. It defines the syndrome as fatigue, diffuse pain, and cognitive dysfunction lasting more than six months after documented, adequately treated Lyme disease, and states that symptoms are not explained by persistent infection.
Its recommended management is multidisciplinary rehabilitation and psychological support. It advises against additional antibiotics and immunomodulatory therapies because of limited efficacy and potential adverse effects.
The plan is long-term, personalized rehabilitation and psychological support, with a clinician who takes the symptoms seriously.
What the 2020 Lab Study Actually Showed
Almost every article on this topic cites one study. Here is what it did.
Feng and colleagues, published in Frontiers in Medicine in 2020, tested 12 botanical medicines and 3 other natural agents against Borrelia burgdorferi in the lab. They looked at growing bacteria and the stationary-phase forms antibiotics often miss.
Seven extracts at 1% showed good activity against stationary-phase bacteria compared with doxycycline and cefuroxime:
- Cryptolepis sanguinolenta
- Black walnut (Juglans nigra)
- Japanese knotweed (Polygonum cuspidatum)
- Sweet wormwood (Artemisia annua)
- Cat's claw (Uncaria tomentosa)
- Cistus incanus
- Chinese skullcap (Scutellaria baicalensis)
Several popular products did little or nothing: stevia, andrographis, grapefruit seed extract, colloidal silver, monolaurin, and the antimicrobial peptide LL37.
The potency numbers were mixed. Cryptolepis had a minimum inhibitory concentration of 0.03% to 0.06% against growing bacteria, and Japanese knotweed 0.25% to 0.5%. Sweet wormwood, black walnut, and cat's claw needed much higher concentrations, even though they did well against the stationary form.
The most quoted result: in subculture, only the 1% cryptolepis extract caused complete eradication. Doxycycline, cefuroxime, and the other active herbs did not clear stationary-phase cells after 21 days.
Now the part the headlines leave out. This was a test-tube study. It measured bacterial survival in a dish, not symptoms in a person. It cannot tell you whether anyone feels better, what dose reaches infected tissue, or whether the effect survives human metabolism. The authors called for further in vitro and in vivo work. That is a reason to hold the finding at the right size.
The Herb-by-Herb Evidence
Lyme disease natural treatment is a crowded search topic, and most Lyme disease supplements sold online are blends of the same handful of herbs. The best summary is a 2023 review by Thompson, Hynicka, and Shere-Wolfe in Integrative Medicine. It examined 18 herbs used for symptoms attributed to Lyme disease.
The herbs for Lyme disease with lab data are a short list. Cat's claw, cryptolepis, Chinese skullcap, Japanese knotweed, sweet wormwood, thyme, and oil of oregano had in vitro anti-Borrelia evidence. Except for oil of oregano, they also showed anti-inflammatory activity.
The conclusion is blunt: "Some herbs demonstrated limited anti-borrelial activity in vitro, but in-vivo data and clinical trial data is lacking."
The two lists differ: Feng's includes black walnut and Cistus incanus, and Thompson's swaps those for thyme and oil of oregano. Neither source merged the other's data.
| Herb | In vitro anti-Borrelia | Anti-inflammatory | Human Lyme data | Key safety note |
|---|---|---|---|---|
| Cat's claw (Uncaria tomentosa) | Yes, at 1% | Yes | None found | GI upset possible. In vitro CYP inhibition seen. |
| Cryptolepis (Cryptolepis sanguinolenta) | Yes, strongest result. MIC 0.03% to 0.06%. | Yes | None found | Toxicity profile unknown. Animal antifertility signals. Avoid in pregnancy. |
| Chinese skullcap (Scutellaria baicalensis) | Yes, at 1% | Yes | None found | Sedation possible. Liver injury reported with a baicalin product. |
| Japanese knotweed (Polygonum cuspidatum) | Yes. MIC 0.25% to 0.5%. | Yes | None found | Thin safety data. Resveratrol can cause GI upset. |
| Sweet wormwood (Artemisia annua) | Yes, at 1% | Yes | None found | Limited data. Wormwood oil sold online linked to acute kidney failure. |
| Thyme (Thymus vulgaris) | Listed by Thompson 2023 | Yes | None found | Generally well tolerated at culinary amounts. High-dose safety not established. |
| Oil of oregano (Origanum vulgare) | Listed by Thompson 2023 | Not established | None found | Generally well tolerated at culinary amounts. High doses can irritate the gut. |
Cat's Claw (Uncaria tomentosa)
Active against stationary-phase Borrelia at 1% in the Feng study. Thompson lists it among the seven with in vitro activity and anti-inflammatory effects. No human trial has tested it for Lyme symptoms. GI upset is possible, and an in vitro study of Samento and Banderol extracts found CYP inhibition, so drug interactions cannot be ruled out.
Cryptolepis (Cryptolepis sanguinolenta)
Cryptolepis is the headline herb in this group, and it has the strongest lab result: a low MIC against growing bacteria, and the only extract that eradicated stationary-phase cells in subculture. That is not a clinical finding. The full human toxicity profile is unknown, and animal studies raise antifertility concerns. Anyone pregnant or trying to conceive should avoid it.
Chinese Skullcap (Scutellaria baicalensis)
Active against stationary-phase bacteria at 1%, with anti-inflammatory activity from baicalein and baicalin. Safety data are mixed. A baicalin-catechin product called flavocoxid was withdrawn from the market after reports of acute liver injury. Skullcap can also cause sedation, and because of the liver-injury signal, anyone with liver disease should ask first.
Japanese Knotweed (Polygonum cuspidatum)
Active in the Feng study, with a MIC of 0.25% to 0.5% against growing bacteria. It is the main commercial source of resveratrol used in supplements. Human safety data for the herb are thin. Resveratrol supplements show minimal toxicity with some GI upset, but that is not long-term safety data for high-dose knotweed.
Sweet Wormwood (Artemisia annua)
Active against stationary-phase bacteria at 1%, though it needed a high concentration to stop growing bacteria. Safety data are limited. Drinking wormwood oil bought online has been linked to acute renal failure. That is a documented harm and a good reason to avoid concentrated oils.
Thyme and Oil of Oregano
Both are listed by Thompson as having in vitro anti-Borrelia activity. Thyme also has anti-inflammatory activity. Oil of oregano is the one herb on that list without it. Both are generally well tolerated at culinary amounts, but high-dose capsules can irritate the stomach, and neither has human Lyme trials.
The Human Evidence Gap
Here is the sentence that matters most: we found no randomized human trial showing that any herb treats Lyme disease.
Not one. There are laboratory studies, long traditional use, and a lot of confident marketing. No human trial shows that any of these herbs improves Lyme symptoms or clears the infection in people.
If a seller tells you otherwise, ask for the trial. A citation to the 2020 lab paper is not a human trial.
The Biofilm Story, Told Honestly
Biofilm comes up constantly in chronic Lyme marketing, usually with the claim that Borrelia hides in a matrix antibiotics cannot reach.
There is some real science here. A 2016 study by Sapi and colleagues found Borrelia biofilm in human skin tissue from borrelial lymphocytomas.
But the clinical leap is not supported. The 2023 review states that no human clinical studies have shown a causative link between Borrelia biofilms and persistent clinical disease.
So biofilm is a reasonable research question and an unreasonable sales pitch. Our biofilm disruptors guide explains what the category claims and where the evidence sits.
What Actually Helps While You Take Antibiotics
This part has real human data, and it is unglamorous.
Probiotics
A 2025 Cochrane review included 47 trials with 15,260 participants. Across 38 of those trials, probiotics may reduce C. difficile-associated diarrhea during antibiotic use from 3.2% to 1.6%, with a relative risk of 0.50 (95% CI 0.38 to 0.64). Across 40 trials, they may also reduce antibiotic-associated diarrhea overall from 27.4% to 23%, with a relative risk of 0.67 (95% CI 0.57 to 0.78).
Both were rated low certainty, which means the direction is promising but the size of the effect is uncertain.
A common spacing convention is to take the probiotic a couple of hours apart from the antibiotic dose. Ask your clinician or pharmacist which strain mix fits you. Our guide to how to choose a probiotic walks through strains and timing.
Doxycycline and Sun Sensitivity
Doxycycline is a well-documented photosensitizing drug. It can make skin react to sunlight faster and more severely than usual.
This is a drug effect, not a nutrient deficiency, and no supplement fixes it. Use sunscreen, cover up, and limit direct sun. If you develop a severe sun reaction, call your clinician.
Nutrient Repletion and Recovery Basics
Illness, poor appetite, and a restricted diet can leave you short on basic nutrients. General nutrition support during recovery is sensible and low risk.
Keep the claim honest: this supports normal nutrition, not curing Lyme disease. If you take long-term medication, our list of medications that deplete nutrients is a useful starting point. Protect sleep and pace activity too, because neither costs anything.
Safety: Interactions, Side Effects, and Who Should Not Take These
The 2023 review warns about additive effects that can raise the risk of bleeding, low blood pressure, and low blood sugar. That warning is aimed at clinicians, but you are buying the bottle.
Do not self-start any of these herbs if you take:
- A blood thinner or antiplatelet drug, including warfarin, apixaban, rivaroxaban, clopidogrel, or daily aspirin.
- Blood pressure medication. Additive lowering can cause dizziness or fainting.
- Insulin or a blood sugar medication. Additive glucose lowering can push you too low.
- A narrow-window drug. The in vitro CYP inhibition data for cat's claw means interactions cannot be ruled out.
- Anything for liver disease. Skullcap and other herbs carry liver signals you should not gamble on.
Stop and call your clinician if you notice unusual bruising or bleeding, dizziness on standing, low blood sugar symptoms, yellowing of the skin or eyes, dark urine, or a new rash.
Pregnancy and Fertility
Cryptolepis is the clearest caution. Animal studies raise antifertility and reproductive toxicity concerns, so avoid it in pregnancy and when trying to conceive. For any herb here, ask your obstetric clinician first.
What About a Herxheimer Reaction?
Some protocols call a worsening of symptoms after starting an antimicrobial herb a Herxheimer reaction. In Lyme treatment, that reaction is usually assumed rather than measured.
Do not treat a severe flare as proof that a product is working. If symptoms escalate, especially with the red flags at the top of this article, get medical care. Our parasite cleanse guide covers how this claim gets used and why the evidence is thin.
What Not to Buy, and What a Test Cannot Tell You
Some products keep selling on hope. Here is what to skip, and why.
- Colloidal silver. Little or no activity against Borrelia in the Feng study, and it can cause a permanent bluish-gray skin discoloration called argyria.
- Grapefruit seed extract. Also little or no activity in the study, and no human Lyme data. Ask your pharmacist before combining it with a prescription medicine.
- Monolaurin. No meaningful activity in the lab work, and no human Lyme data.
- Stevia extracts sold as antimicrobials. No activity in the study.
- High-dose essential oils taken internally. No human data, real risk of gut and liver harm, and a documented case of kidney failure with wormwood oil.
- "Provoked" or "unmasking" test kits. Standard two-tier antibody testing is the accepted approach, and it can be negative early. No herb has been shown to turn a negative test positive reliably.
- Any product that promises to cure, erase, or prevent Lyme disease. That claim is not allowed, and it is not true.
Price is not evidence. A $90 bottle and a $12 bottle face the same question: is there human data, and is it safe for you.
Coinfections: When It Is Not Only Lyme
Ticks can carry more than Borrelia. Babesia, Anaplasma, and Bartonella are separate infections with their own diagnosis and treatment.
Babesiosis has its own IDSA guideline, published in 2021. Anaplasma and Bartonella also need clinical diagnosis.
A generic herbal protocol does not cover these infections, and treating them as if it does can delay care that works. Tell your clinician about tick exposure, travel, and the full set of symptoms.
Lingering symptoms can also come from something else. If you have been unwell since a water leak, a damp building, or a move, our guide to mold illness explains why that belongs on the list. At Agape Nutrition, we would rather point you toward the right question than sell you a bottle that answers the wrong one.
What We Recommend
These are adjunct supports to discuss with a clinician, not treatments for Lyme disease, and none of them replaces antibiotics.
Researched Nutritionals, Transfer Factor Multi-Immune 90 Capsules
An immune-support blend of transfer factor, mushroom extracts, zinc, and selenium for periods of higher demand.
$56.98
Researched Nutritionals, Crypto-Plus™ 4 oz
An herbal microbial-balance tincture with a phospholipid delivery system, for general microbial-balance support.
$79.98
Allergy Research Group, Cat's Claw 60 Veg Capsules
An inner-bark extract of Uncaria tomentosa.
$42.89
Frequently Asked Questions
Can supplements replace antibiotics for Lyme disease?
No. Antibiotics are first-line for Lyme disease, and early treatment usually leads to full recovery. No supplement has been shown in a human trial to clear the infection. Never stop, delay, or shorten a prescribed course for a herbal product.
What herbs have been studied for Lyme disease?
The 2020 Feng lab study found activity in cryptolepis, black walnut, Japanese knotweed, sweet wormwood, cat's claw, Cistus incanus, and Chinese skullcap. The 2023 Thompson review named a different seven: cat's claw, cryptolepis, Chinese skullcap, Japanese knotweed, sweet wormwood, thyme, and oil of oregano. All of it is laboratory data.
Does cryptolepis kill Lyme bacteria?
In a test tube, a 1% cryptolepis extract was the only one in the Feng study that completely eradicated stationary-phase Borrelia in subculture. That is a lab result. No human trial has shown that taking it clears an infection or improves symptoms.
What is PTLDS?
Post-treatment Lyme disease syndrome is fatigue, widespread pain, and cognitive trouble lasting more than six months after documented, adequately treated Lyme disease. It affects a minority of patients, and the symptoms are real. Ongoing infection is not supported as the cause in most cases.
Should I take probiotics with doxycycline?
Probiotics have the best human evidence of anything here for antibiotic support. A 2025 Cochrane review found they may reduce antibiotic-associated diarrhea and C. difficile infections. A common spacing convention is a couple of hours apart from the antibiotic dose. Confirm the choice with your clinician.
Can I take herbs with blood thinners?
Not without your clinician's approval. Several of these herbs can add to bleeding risk, and the 2023 review warns about additive effects with anticoagulants, blood pressure drugs, and diabetes medication. The same applies to insulin and narrow-window drugs.
How long do Lyme symptoms last after treatment?
Most people treated early recover within weeks. A minority report fatigue, pain, or brain fog lasting more than six months, which is PTLDS. If symptoms persist, work with a clinician on sleep, pacing, rehabilitation, and other causes rather than self-prescribing.
References
- Lantos PM, Rumbaugh J, Bockenstedt LK, et al. Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease. Clin Infect Dis. 2021;72(1):e1-e48. https://pubmed.ncbi.nlm.nih.gov/33417672/
- Centers for Disease Control and Prevention. Lyme disease treatment. https://www.cdc.gov/lyme/treatment/index.html
- Feng J, Leone J, Schweig S, Zhang Y. Evaluation of Natural and Botanical Medicines for Activity Against Growing and Non-growing Forms of B. burgdorferi. Front Med (Lausanne). 2020;7:6. https://pubmed.ncbi.nlm.nih.gov/32154254/
- Thompson A, Hynicka LM, Shere-Wolfe KD. A Comprehensive Review of Herbal Supplements Used for Persistent Symptoms Attributed to Lyme Disease. Integr Med (Encinitas). 2023;22(1):30-38. https://pmc.ncbi.nlm.nih.gov/articles/PMC10124234/
- Klempner MS, Hu LT, Evans J, et al. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med. 2001;345(2):85-92. https://pubmed.ncbi.nlm.nih.gov/11450676/
- Fallon BA, Keilp JG, Corbera KM, et al. A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurology. 2008;70(13):992-1003. https://pubmed.ncbi.nlm.nih.gov/17928580/
- Berende A, ter Hofstede HJ, Vos FJ, et al. Randomized Trial of Longer-Term Therapy for Symptoms Attributed to Lyme Disease. N Engl J Med. 2016;374(13):1209-1220. https://pubmed.ncbi.nlm.nih.gov/27028911/
- Aucott JN, Yang T, Yoon I, Powell D, Geller SA, Rebman AW. Risk of post-treatment Lyme disease in patients with ideally-treated early Lyme disease: A prospective cohort study. Int J Infect Dis. 2022;116:230-237. https://pubmed.ncbi.nlm.nih.gov/35066160/
- Arias P, Gocko X, Roblot F, Hansmann Y, Baux E, Eldin C. Guidelines for Lyme borreliosis: post-treatment Lyme disease syndrome (PTLDS). Infect Dis Now. 2025;55:105205. https://pubmed.ncbi.nlm.nih.gov/41314472/
- Krause PJ, Auwaerter PG, Bannuru RR, et al. Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA): 2020 Guideline on Diagnosis and Management of Babesiosis. Clin Infect Dis. 2021;72(2):e49-e64. https://pubmed.ncbi.nlm.nih.gov/33252652/
- Esmaeilinezhad Z, Ghosh NR, Walsh CM, Steen JP, Burgman AM, Mertz D. Probiotics for the prevention of Clostridioides difficile-associated diarrhea in adults and children. Cochrane Database Syst Rev. 2025;9(9):CD006095. https://pubmed.ncbi.nlm.nih.gov/40931979/
- Montgomery S, Worswick S. Photosensitizing drug reactions. Clin Dermatol. 2022;40(1):57-63. https://pubmed.ncbi.nlm.nih.gov/35190066/
- Sapi E, Balasubramanian K, Poruri A, et al. Evidence of In Vivo Existence of Borrelia Biofilm in Borrelial Lymphocytomas. Eur J Microbiol Immunol (Bp). 2016;6(1):9-24. https://pubmed.ncbi.nlm.nih.gov/27141311/
- Weiss J. Herb-Drug Interaction Potential of Anti-Borreliae Effective Extracts from Uncaria tomentosa (Samento) and Otoba parvifolia (Banderol) Assessed In Vitro. Molecules. 2018;24(1). https://pubmed.ncbi.nlm.nih.gov/30602711/
- Davis AE, Kennelley GE, Amaye-Obu T, et al. The phenomenon of phototoxicity and long-term risks of commonly prescribed and structurally diverse drugs. J Photochem Photobiol. 2024;19. https://pubmed.ncbi.nlm.nih.gov/38389933/
- Simon M, Buchanan JA. Argyria, an Unexpected Case of Skin Discoloration From Colloidal Silver Salt Ingestion. J Emerg Med. 2021;59(2):e39-e41. https://pubmed.ncbi.nlm.nih.gov/32591303/
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
